Avanos Medical, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- David C. Pacitti
- Full Time Employees
- 2,227
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 5405 Windward Parkway Alpharetta GA United States of America 30004
- IPO Date
- Oct 21, 2014
- CIK
- 0001606498
- Website
- avanos.com
- Similar Companies
- Business
- Avanos Medical, Inc. Avanos Medical, Inc. (AVNS) develops, manufactures and markets medical devices focused on pain management and recovery and specialty nutrition systems including enteral feeding. The company offers a broad portfolio of products such as the COOLIEF cooled radiofrequency ablation system and TRIDENT hybrid cannula for chronic pain treatment via radiofrequency nerve ablation; ON-Q elastomeric and ambIT electronic ambulatory pain pumps for post-surgical pain control; GAME READY cryocompression therapy systems for injury and surgical recovery; TriVisc and GenVisc850 hyaluronic acid injections for osteoarthritis knee pain; MIC-KEY low-profile and MIC PEG feeding tubes, CORTRAK2 enteral access system, CORFLO nasogastric/nasointestinal tubes, NEOMED neonatal feeding solutions, FARRELL valve system for gastric decompression and CORGRIP tube retention devices for digestive health and enteral nutrition across neonates, pediatrics and adults. Avanos Medical serves hospitals, ambulatory surgery centers, pain clinics, critical care units, neonatologists and healthcare providers worldwide in over 90 countries through direct sales and distributors. Headquartered in Alpharetta, Georgia and founded in 2014 as a spin-off from Kimberly-Clark Corporation, the company rebranded from Halyard Health in 2018 and operates two primary segments of pain management and chronic care. In September 2025, Avanos Medical acquired Nexus Medical, LLC, integrating its TKO anti-reflux needleless connector technology to enhance nutrition and medication delivery in critical care, neonatal and pediatric intensive care units, bolstering the specialty nutrition systems division with immediate revenue and earnings accretion. The company reported double-digit growth in its specialty nutrition systems segment during third quarter 2025, driven by strong product demand and the Nexus integration.
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders?
Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—TMHC, CZR, XOMA, and AVNS
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Are CZR, AVNS, GBTG Obtaining Fair Deals for their Shareholders?
$HAREHOLDER ALERT: The M&A Class Action Launches Legal Inquiry for the Merger--AFBI, QXO, BLD, and AVNS
New Strong Sell Stocks for May 15th
Deciphering Avanos Medical (AVNS) International Revenue Trends
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Helix Energy Solutions Group, Inc. (NYSE – HLX), TopBuild Corp. (NYSE – BLD), Avanos Medical, Inc. (NYSE – AVNS), Affinity Bancshares (Nasdaq – AFBI)
Avanos Medical (AVNS) Lags Q1 Earnings Estimates
Avanos Medical, Inc. Announces First Quarter 2026 Results
Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders
Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS
Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium
Avanos Medical Inc (AVNS) Stock Up 69.5% but GF Value Says Overvalued -- GF Score: 73/100